140 related articles for article (PubMed ID: 8410970)
1. Structure-activity relationships of C-terminal endothelin hexapeptide antagonists.
Doherty AM; Cody WL; DePue PL; He JX; Waite LA; Leonard DM; Leitz NL; Dudley DT; Rapundalo ST; Hingorani GP
J Med Chem; 1993 Sep; 36(18):2585-94. PubMed ID: 8410970
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo studies with a series of hexapeptide endothelin antagonists.
Doherty AM; Cody WL; He JX; DePue PL; Cheng XM; Welch KM; Flynn MA; Reynolds EE; LaDouceur DM; Davis LS
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S98-102. PubMed ID: 7510009
[TBL] [Abstract][Full Text] [Related]
3. Design of a functional hexapeptide antagonist of endothelin.
Cody WL; Doherty AM; He JX; DePue PL; Rapundalo ST; Hingorani GA; Major TC; Panek RL; Dudley DT; Haleen SJ
J Med Chem; 1992 Aug; 35(17):3301-3. PubMed ID: 1324321
[No Abstract] [Full Text] [Related]
4. Structure-activity relationships of the potent combined endothelin-A/endothelin-B receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21: development of endothelin-B receptor selective antagonists.
Cody WL; He JX; DePue PL; Waite LA; Leonard DM; Sefler AM; Kaltenbronn JS; Haleen SJ; Walker DM; Flynn MA
J Med Chem; 1995 Jul; 38(15):2809-19. PubMed ID: 7636842
[TBL] [Abstract][Full Text] [Related]
5. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
Warner TD; Allcock GH; Corder R; Vane JR
Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 (ET-1)-induced contraction in rat isolated trachea: involvement of ETA and ETB receptors and multiple signal transduction systems.
Henry PJ
Br J Pharmacol; 1993 Sep; 110(1):435-41. PubMed ID: 8220905
[TBL] [Abstract][Full Text] [Related]
7. Predominance of endothelinA (ETA) receptors in ovine airway smooth muscle and their mediation of ET-1-induced contraction.
Goldie RG; Grayson PS; Knott PG; Self GJ; Henry PJ
Br J Pharmacol; 1994 Jul; 112(3):749-56. PubMed ID: 7921598
[TBL] [Abstract][Full Text] [Related]
8. Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties.
Cody WL; He JX; Reily MD; Haleen SJ; Walker DM; Reyner EL; Stewart BH; Doherty AM
J Med Chem; 1997 Jul; 40(14):2228-40. PubMed ID: 9216842
[TBL] [Abstract][Full Text] [Related]
9. Toward the rational development of peptidomimetic analogs of the C-terminal endothelin hexapeptide: development of a theoretical model.
Macchia M; Barontini S; Ceccarelli F; Galoppini C; Giusti L; Hamdan M; Lucacchini A; Martinelli A; Menchini E; Mazzoni MR; Revoltella RP; Romagnoli F; Rovero P
Farmaco; 1998; 53(8-9):545-56. PubMed ID: 10081817
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity studies of endothelin leading to novel peptide ETA antagonists.
Hunt JT; Lee VG; McMullen D; Liu EC; Bolgar M; Delaney CL; Festin SM; Floyd DM; Hedberg A; Natarajan S
Bioorg Med Chem; 1993 Jul; 1(1):59-65. PubMed ID: 8081838
[TBL] [Abstract][Full Text] [Related]
11. Functional role of endothelin ETA and ETB receptors in venous and arterial smooth muscle.
Lodge NJ; Zhang R; Halaka NN; Moreland S
Eur J Pharmacol; 1995 Dec; 287(3):279-85. PubMed ID: 8991802
[TBL] [Abstract][Full Text] [Related]
12. Synergistic inhibition by BQ-123 and BQ-788 of endothelin-1-induced contractions of the rabbit pulmonary artery.
Fukuroda T; Ozaki S; Ihara M; Ishikawa K; Yano M; Nishikibe M
Br J Pharmacol; 1994 Oct; 113(2):336-8. PubMed ID: 7834180
[TBL] [Abstract][Full Text] [Related]
13. Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.
Hay DW; Luttmann MA; Beck G; Ohlstein EH
Br J Pharmacol; 1996 Jul; 118(5):1209-17. PubMed ID: 8818345
[TBL] [Abstract][Full Text] [Related]
14. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
Warner TD; Allcock GH; Vane JR
Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-1 analogues substituted at both position 18 and 19: highly potent endothelin antagonists with no selectivity for either receptor subtype ETA or ETB.
Kikuchi T; Kubo K; Ohtaki T; Suzuki N; Asami T; Shimamoto N; Wakimasu M; Fujino M
J Med Chem; 1993 Dec; 36(25):4087-93. PubMed ID: 8258832
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the binding of endothelin ETB selective ligands in human and rat heart.
Russell FD; Davenport AP
Br J Pharmacol; 1996 Oct; 119(4):631-6. PubMed ID: 8904635
[TBL] [Abstract][Full Text] [Related]
17. Characterization of iris sphincter smooth muscle endothelin receptor subtypes which are coupled to cyclic AMP formation and polyphosphoinositide hydrolysis.
el-Mowafy AM; Abdel-Latif AA
J Pharmacol Exp Ther; 1994 Mar; 268(3):1343-51. PubMed ID: 8138949
[TBL] [Abstract][Full Text] [Related]
18. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor.
Ihara M; Noguchi K; Saeki T; Fukuroda T; Tsuchida S; Kimura S; Fukami T; Ishikawa K; Nishikibe M; Yano M
Life Sci; 1992; 50(4):247-55. PubMed ID: 1310132
[TBL] [Abstract][Full Text] [Related]
19. The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta.
Webb ML; Dickinson KE; Delaney CL; Liu EC; Serafino R; Cohen RB; Monshizadegan H; Moreland S
Biochem Biophys Res Commun; 1992 Jun; 185(3):887-92. PubMed ID: 1320879
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity studies of the C-terminal region of the endothelins and the sarafotoxins.
Doherty AM; Cody WL; Leitz NL; DePue PL; Taylor MD; Rapundalo ST; Hingorani GP; Major TC; Panek RL; Taylor DG
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S59-61. PubMed ID: 1725433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
